162 related articles for article (PubMed ID: 7551881)
1. An open, in-patient incremental safety and efficacy study of desmopressin in women with multiple sclerosis and nocturia.
Eckford SD; Carter PG; Jackson SR; Penney MD; Abrams P
Br J Urol; 1995 Oct; 76(4):459-63. PubMed ID: 7551881
[TBL] [Abstract][Full Text] [Related]
2. Desmopressin in the treatment of nocturia and enuresis in patients with multiple sclerosis.
Eckford SD; Swami KS; Jackson SR; Abrams PH
Br J Urol; 1994 Dec; 74(6):733-5. PubMed ID: 7827843
[TBL] [Abstract][Full Text] [Related]
3. Desmopressin for nocturia and enuresis associated with multiple sclerosis.
Ferreira E; Letwin SR
Ann Pharmacother; 1998 Jan; 32(1):114-6. PubMed ID: 9475830
[No Abstract] [Full Text] [Related]
4. Desmopressin in the management of nocturia in patients with multiple sclerosis. A double-blind, crossover trial.
Valiquette G; Herbert J; Maede-D'Alisera P
Arch Neurol; 1996 Dec; 53(12):1270-5. PubMed ID: 8970454
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of desmopressin (Minirin) in the treatment of nocturia: a double-blind placebo-controlled study in women.
Lose G; Lalos O; Freeman RM; van Kerrebroeck P;
Am J Obstet Gynecol; 2003 Oct; 189(4):1106-13. PubMed ID: 14586363
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of desmopressin in patients with multiple sclerosis suffering from bladder dysfunction: a meta-analysis.
Bosma R; Wynia K; Havlíková E; De Keyser J; Middel B
Acta Neurol Scand; 2005 Jul; 112(1):1-5. PubMed ID: 15932348
[TBL] [Abstract][Full Text] [Related]
7. Desmopressin in the treatment of daytime urinary frequency in patients with multiple sclerosis.
Hoverd PA; Fowler CJ
J Neurol Neurosurg Psychiatry; 1998 Nov; 65(5):778-80. PubMed ID: 9810957
[TBL] [Abstract][Full Text] [Related]
8. Desmopressin in elderly patients with nocturia: short-term safety and effects on urine output, sleep and voiding patterns.
Rembratt A; Norgaard JP; Andersson KE
BJU Int; 2003 May; 91(7):642-6. PubMed ID: 12699476
[TBL] [Abstract][Full Text] [Related]
9. Desmopressin treatment in nocturia; an analysis of risk factors for hyponatremia.
Rembratt A; Riis A; Norgaard JP
Neurourol Urodyn; 2006; 25(2):105-9. PubMed ID: 16304673
[TBL] [Abstract][Full Text] [Related]
10. Gender difference in efficacy and dose response in Japanese patients with nocturia treated with four different doses of desmopressin orally disintegrating tablet in a randomized, placebo-controlled trial.
Yamaguchi O; Nishizawa O; Juul KV; Nørgaard JP
BJU Int; 2013 Mar; 111(3):474-84. PubMed ID: 23046147
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of desmopressin in the treatment of nocturia: a double-blind placebo-controlled study in men.
Mattiasson A; Abrams P; Van Kerrebroeck P; Walter S; Weiss J
BJU Int; 2002 Jun; 89(9):855-62. PubMed ID: 12010228
[TBL] [Abstract][Full Text] [Related]
12. The use of desmopressin (DDAVP) for nocturia in women with multiple sclerosis.
Hilton P; Hertogs K; Stanton SL
J Neurol Neurosurg Psychiatry; 1983 Sep; 46(9):854-5. PubMed ID: 6619893
[TBL] [Abstract][Full Text] [Related]
13. Spot urine osmolality, age and bladder capacity as predictors of response to desmopressin in nocturnal enuresis.
Eller DA; Homsy YL; Austin PF; Tanguay S; Cantor A
Scand J Urol Nephrol Suppl; 1997; 183():41-5. PubMed ID: 9165605
[TBL] [Abstract][Full Text] [Related]
14. The role of desmopressin in the treatment of adult nocturia.
Abrams P; Mattiasson A; Lose GR; Robertson GL
BJU Int; 2002 Dec; 90 Suppl 3():32-6. PubMed ID: 12445098
[No Abstract] [Full Text] [Related]
15. Daytime functional bladder capacity as a predictor of response to desmopressin in monosymptomatic nocturnal enuresis.
Eller DA; Austin PF; Tanguay S; Homsy YL
Eur Urol; 1998; 33 Suppl 3():25-9. PubMed ID: 9599733
[TBL] [Abstract][Full Text] [Related]
16. Desmopressin: in adults with nocturia.
Cvetković RS; Plosker GL
Drugs; 2005; 65(1):99-107; discussion 108-9. PubMed ID: 15610055
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of desmopressin in treatment of refractory nocturia in patients older than 65 years.
Kuo HC
Urology; 2002 Apr; 59(4):485-9. PubMed ID: 11927295
[TBL] [Abstract][Full Text] [Related]
18. Long term use of desmopressin for urinary symptoms in multiple sclerosis.
Tubridy N; Addison R; Schon F
Mult Scler; 1999 Dec; 5(6):416-7. PubMed ID: 10618698
[TBL] [Abstract][Full Text] [Related]
19. Desmopressin for nocturnal enuresis: urinary osmolality and response.
Folwell AJ; Macdiarmid SA; Crowder HJ; Lord AD; Arnold EP
Br J Urol; 1997 Sep; 80(3):480-4. PubMed ID: 9313673
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study.
Sand PK; Dmochowski RR; Reddy J; van der Meulen EA
J Urol; 2013 Sep; 190(3):958-64. PubMed ID: 23454404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
